Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2, published by HL7 Clinical Decision Support Workgroup. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions
Draft as of 2018-07-02 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="valueset-rimexolone"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>220785</td><td>Vexol</td></tr><tr><td>55681</td><td>rimexolone</td></tr><tr><td>207446</td><td>rimexolone 10 MG/ML Ophthalmic Suspension [Vexol]</td></tr><tr><td>568209</td><td>rimexolone 10 MG/ML [Vexol]</td></tr><tr><td>365826</td><td>rimexolone Ophthalmic Suspension [Vexol]</td></tr><tr><td>199115</td><td>rimexolone 10 MG/ML Ophthalmic Suspension</td></tr><tr><td>328510</td><td>rimexolone 10 MG/ML</td></tr><tr><td>379299</td><td>rimexolone Ophthalmic Suspension</td></tr><tr><td>1157440</td><td>rimexolone Ophthalmic Product</td></tr><tr><td>1188083</td><td>Vexol Ophthalmic Product</td></tr></table></li></ul></div>
</text>
<url value="http://hl7.org/fhir/uv/pddi/ValueSet/valueset-rimexolone"/>
<version value="1.0.0-ballot"/>
<name value="Valueset_rimexolone"/>
<title value="Rimexolone Medications Value Set"/>
<status value="draft"/>
<experimental value="true"/>
<date value="2018-07-02"/>
<publisher value="HL7 Clinical Decision Support Workgroup"/>
<contact>
<telecom>
<system value="url"/>
<value value="http://hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description value="ValueSet containing drug identifiers for rimexolone."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
</coding>
</jurisdiction>
<copyright value="(copyright expectations unknown)"/>
<compose>
<include>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<concept>
<code value="220785"/>
<display value="Vexol"/>
</concept>
<concept>
<code value="55681"/>
<display value="rimexolone"/>
</concept>
<concept>
<code value="207446"/>
<display value="rimexolone 10 MG/ML Ophthalmic Suspension [Vexol]"/>
</concept>
<concept>
<code value="568209"/>
<display value="rimexolone 10 MG/ML [Vexol]"/>
</concept>
<concept>
<code value="365826"/>
<display value="rimexolone Ophthalmic Suspension [Vexol]"/>
</concept>
<concept>
<code value="199115"/>
<display value="rimexolone 10 MG/ML Ophthalmic Suspension"/>
</concept>
<concept>
<code value="328510"/>
<display value="rimexolone 10 MG/ML"/>
</concept>
<concept>
<code value="379299"/>
<display value="rimexolone Ophthalmic Suspension"/>
</concept>
<concept>
<code value="1157440"/>
<display value="rimexolone Ophthalmic Product"/>
</concept>
<concept>
<code value="1188083"/>
<display value="Vexol Ophthalmic Product"/>
</concept>
</include>
</compose>
</ValueSet>